Innovative lung cancer drug approved in UAE

www.lumakras.com

The UAE has become the second country in the world to approve the new lung cancer drug 'Lumakras'.

The Ministry of Health and Prevention (MoHAP) has cleared the registration and use of the drug, which recently received the approval of the US Food and Drug Administration (FDA).

It will help speed up the treatment plan of patients in the UAE and improve their quality of life.

Lumakras, manufactured by Amgen, is prescribed to adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), who have received at least one previous cancer therapy.

It is supplied as film-coated tablets for oral use containing 120 mg of sotorasib.

More from UAE

On Virgin Radio today

  • Non Stop Hits

    Midnight - 6:00am

    The UAE's #1 Hit Music Station with no interruptions

  • The Kris Fade Show

    6:00am - 10:00am

    Kris, Priti and Rossi host the UAE's biggest radio show. It's full of fun, laughs and it's Where The Stars Live.

Hit Music